Quick Answer
RedHill Biopharma Ltd. reported Total Assets of $18.04 million for fiscal year 2024.
RedHill Biopharma Ltd. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2024 | $18.04M | -21.7% |
| 2023 | $23.05M | -85.5% |
| 2022 | $158.87M | -12.3% |
| 2021 | $181.19M | +0.5% |
| 2020 | $180.24M | +143.2% |
| 2019 | $74.10M | +18.7% |
| 2018 | $62.41M | +8.8% |
| 2017 | $57.34M | -22.7% |
| 2016 | $74.21M | — |
- RedHill Biopharma Ltd. showed a decrease of -21.7% in Total Assets compared to the prior fiscal year.
- Over the 2016–2024 period, RedHill Biopharma Ltd.’s total assets has declined by 75.7% (from $74.21 million to $18.04 million).
- The most recent figure is from RedHill Biopharma Ltd.’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 10, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: